Implementing Pharmacogenomics at Your Institution: Establishment and Overcoming Implementation Challenges
Open Access
- 14 June 2016
- journal article
- Published by Wiley in Clinical and Translational Science
- Vol. 9 (5), 233-245
- https://doi.org/10.1111/cts.12404
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U01 HG007269, K23 HL112908, K23 GM112014)
This publication has 47 references indexed in Scilit:
- Implementation of pharmacogenetics: The University of Maryland personalized anti‐platelet pharmacogenetics programSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2014
- Stakeholder Views on Pharmacogenomic TestingPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Pharmacogenetics and Cardiovascular Disease—Implications for Personalized MedicinePharmacological Reviews, 2013
- Institutional Profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogeneticsPharmacogenomics, 2013
- The CLIPMERGE PGx Program: Clinical Implementation of Personalized Medicine Through Electronic Health Records and Genomics–PharmacogenomicsClinical Pharmacology & Therapeutics, 2013
- The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of PharmacogenomicsClinical Pharmacology & Therapeutics, 2012
- Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT ProjectClinical Pharmacology & Therapeutics, 2012
- Genetic Polymorphisms of Drug-Metabolising Enzymes and Drug Transporters in the Chemotherapeutic Treatment of CancerClinical Pharmacokinetics, 2006
- Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseMolecular Psychiatry, 2004
- Hypothesis: Comparisons of inter- and intra-individual variations can substitute for twin studies in drug researchPharmacogenetics, 1998